Faulty device didn't distort Xarelto trial results-EU watchdog

FRANKFURT, Feb 5 (Reuters) - Europe's drug regulator said on Friday the defective blood clotting test device used in a key trial for the approval of Bayer's top-selling anti-clotting drug Xarelto did...